As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.
| Mar '25 | 
         
    +/-
   
  
    %
   
 | 
      ||
| Revenue | 1.74 1.74 | 
         
      
        
        10%
      
      
        
        10%
      
 
        
       | 
      |
| Gross Profit | 0.37 0.37 | 
         
      
        
        33%
      
      
        
        33%
      
 
        
       | 
      |
| EBITDA | -2.60 -2.60 | 
         
      
        
        13%
      
      
        
        13%
      
 
        
       | 
      |
| EBIT (Operating Income) EBIT | -2.68 -2.68 | 
         
      
        
        7%
      
      
        
        7%
      
 
        
       | 
      |
| Net Profit | -3.30 -3.30 | 
         
      
        
        6%
      
      
        
        6%
      
 
        
       | 
      |
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Its product categories includes directly-oral, after-soaking-oral, fine, and regular TCMP. It distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
| Head office | Virgin Islands, British | 
| CEO | Sze Zhou | 
| Employees | 75 | 
| Founded | 2005 | 
| Website | www.sxtchina.com | 
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


